The world’s second-largest drug company agreed to new marketing rules for narcotic painkillers, including disclosures of a serious risk for addiction — even with proper use — and a promise to avoid promoting such medications for unapproved uses. Critics of the pharmaceutical industry say aggressive marketing has led to an epidemic of opioid abuse.
   
 
News Alert Tue., Jul. 05, 2016 10:03 p.m.
  
 
Pfizer to disclose opioid addiction risks
The world’s second-largest drug company agreed to new marketing rules for narcotic painkillers, including disclosures of a serious risk for addiction — even with proper use — and a promise to avoid promoting such medications for unapproved uses. Critics of the pharmaceutical industry say aggressive marketing has led to an epidemic of opioid abuse.
Read more »
Advertisement